Moderna Poised to Seek Flu Shot Approval Following Trial Results
Moderna Inc. said a reformulated version of its messenger-RNA based flu shot met its primary goals in a final-stage trial — a result that could pave the way for the company to seek regulatory approval for the influenza vaccine. #press
